---
figid: PMC5833693__41419_2018_332_Fig6_HTML
figlink: /pmc/articles/PMC5833693/figure/Fig6/
number: Fig. 6
caption: A schematic diagram illustrating a possible GM-CSF-induced ERK1/2 signaling
  pathway in monocytes which is inhibited by a GC leading to Bad deactivation and
  subsequent apoptosis. GM-CSF binding to its receptor activates a Raf/MEK/ERK signaling
  cascade leading in turn to ribosomal associated p90RSK kinase activation. The pro-apoptotic
  Bad protein is phosphorylated by p90RSK and subsequently binds to the cytoskeletal
  scaffold protein, 14-3-3. In the absence of a growth factor or upon inhibition of
  the Raf/MEK/ERK pathway by the pharmacological inhibitor (U0126) or a GC-induced
  phosphatase(s), p90RSK remains inactivated and is unable to phosphorylate Bad. Non-phosphorylated
  Bad in turn can interfere with the anti-apoptotic proteins, Bcl-xL and Bcl2, resulting
  in loss of mitochondrial membrane integrity and ultimately apoptosis
pmcid: PMC5833693
papertitle: Glucocorticoids promote apoptosis of proinflammatory monocytes by inhibiting
  ERK activity.
reftext: Adrian Achuthan, et al. Cell Death Dis. 2018 Mar;9(3):267.
pmc_ranked_result_index: '45386'
pathway_score: 0.9677495
filename: 41419_2018_332_Fig6_HTML.jpg
figtitle: Glucocorticoid-induced apoptotic signaling pathway
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5833693__41419_2018_332_Fig6_HTML.html
  '@type': Dataset
  description: A schematic diagram illustrating a possible GM-CSF-induced ERK1/2 signaling
    pathway in monocytes which is inhibited by a GC leading to Bad deactivation and
    subsequent apoptosis. GM-CSF binding to its receptor activates a Raf/MEK/ERK signaling
    cascade leading in turn to ribosomal associated p90RSK kinase activation. The
    pro-apoptotic Bad protein is phosphorylated by p90RSK and subsequently binds to
    the cytoskeletal scaffold protein, 14-3-3. In the absence of a growth factor or
    upon inhibition of the Raf/MEK/ERK pathway by the pharmacological inhibitor (U0126)
    or a GC-induced phosphatase(s), p90RSK remains inactivated and is unable to phosphorylate
    Bad. Non-phosphorylated Bad in turn can interfere with the anti-apoptotic proteins,
    Bcl-xL and Bcl2, resulting in loss of mitochondrial membrane integrity and ultimately
    apoptosis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - BAD
  - SOS1
  - SHC2
  - SHC4
  - BCL2
  - MAPK3
  - SOS2
  - MAP2K2
  - SHC3
  - BCL2L1
  - RAF1
  - YWHAQ
  - HRAS
  - SHC1
  - NRAS
  - GRB2
  - BRAF
  - KRAS
  - CSF2
  - RPS6KA6
  - RPS6KA2
  - RPS6KA3
  - ARAF
  - RPS6KA5
  - RPS6KA1
  - RPS6KA4
  - MAP2K1
  - U0126
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Bad
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: Bcl2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: Bcl-xL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: GM-ÄŒSF
  symbol: GM-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF2
  entrez: '1437'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: MEK1/2E
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals:
- word: U0126
  source: MESH
  identifier: C113580
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
